Canephron®
Bionorica CE
879 Items
2019-09-19
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
Canephron H is a combination preparation of plant origin. It has a complex effect: diuretic, antispasmodic, anti-inflammatory and antibacterial.
Indications
- chronic cystitis and pyelonephritis;
- chronic glomerulonephritis, chronic interstitial nephritis;
- prevention of urolithiasis (including after the removal of stones).
Composition
100 g contain water-alcohol extract * 29 g
* - for preparation of 100 g of aqueous-alcoholic extract 600 mg of centaury herb, 600 mg of lovage root, 600 mg of rosemary leaves are used. Other ingredients: ethanol 16.0-19.5 vol.%, Purified water.
Canephron® is marketed under different brands and generic names, and comes in different dosage forms:
| Brand name | Manufacturer | Country | Dosage form |
|---|---|---|---|
| Canephron | Bionorica CE | Germany | drops |
| Canephron | Bionorica CE | Germany | dragee |
No customer reviews for the moment.
Dosage and Administration
Inside, without chewing, washing down with a small amount of water.
Adults: 2 pills 3 times a day.
School children: 1 pill 3 times a day.
After weakening the severity of the disease should continue treatment with Kanefron N for 2-4 weeks.
Adverse reactions
Maybe: allergic reactions to the components of the drug.
Contraindications
Individual hypersensitivity to the components of the drug Canephron N.
Drug interactions
The use of Canephron N in combination with antibacterial drugs increases the effectiveness of antibacterial therapy.
Interaction with other drugs is still not known.
Pregnancy and Lactation
The question of the possibility of using the drug during pregnancy and lactation (breastfeeding) is decided by the doctor individually.
Special instructions
Canephron H can be prescribed for both basic therapy and as an additional agent.
Influence on ability to drive motor transport and control mechanisms
The drug does not reduce the ability to manage vehicles and working with machines.
- Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia
- Effect of the Herbal Combination Canephron N on Diabetic Nephropathy in Patients with Diabetes Mellitus: Results of a Comparative Cohort Study
- Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia
- Effects of the herbal combination Canephron® N on urinary risk factors of idiopathic calcium urolithiasis in an open study
- Safety of Canephron® N for the treatment of urinary tract infections in the first trimester of pregnancy
- Efficiency of Canephron N in complex treatment of experimental heymann glomerulonephritis
- An open label, non-controlled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the management of uncomplicated urinary tract infections (uUTIs)
- Canephron® N in the treatment of recurrent cystitis in women of child-bearing Age: a randomised controlled study
- Canephron N reduced immune cell recruitment in experimental cystitis
- Canephron® N (BNO 1045) may be Non-inferior to Single-dose Fosfomycin in Reducing the Need for Additional Antibiotics to Treat Women with Presumptive Uncomplicated Urinary Tract Infections
Customers who bought this product also bought:
8 other products in the same category:
arrow_upward